精神分裂症中改变的脂质组学生物标志:系统性审查
Alexandros Messinis1, Eirini Panteli1, Aristea Paraskevopoulou1
1Department of Biological Applications and Technology, University of Ioannina, 45110 Ioannina, Greece.
Schizophrenia research
|August 14, 2024
概括
脂质组学研究揭示了精神分裂症中变化的脂质样本,为疾病的分子基础提供了新的见解. 本综述综合了当前的发现,突出了大脑和血液中的模式,以促进对精神分裂症病理生物学的理解.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 基因组学就是基因组学.
背景情况:
- 精神分裂症是一种复杂的神经精神疾病,具有识别的分子特征.
- 脂质失调是精神分裂症病理生物学中经常出现的观察现象.
- 脂质组学是研究这些脂质谱的新兴工具.
研究的目的:
- 审查和综合从精神分裂症的人类脂质组学研究的发现.
- 在大脑和外围样本中识别常见的脂管学模式.
- 突出目前精神分裂症脂管学研究的局限性和未来方向.
主要方法:
- 对精神分裂症中的脂质组学研究进行全面的文献搜索.
- 包括/排除标准集中在使用脑和血液样本 (血清,血,血小板,红细胞) 的人类研究上.
- 对18项选定的研究进行分析 (5项是大脑,12项是外围,一项是两者).
主要成果:
- 对18项关于精神分裂症的人类研究的脂管学数据的审查.
- 在大脑和外围组织中识别脂质组学模式.
- 对精神分裂症中脂质失调的研究结果的综合.
结论:
- 脂质组学为精神分裂症病理生物学提供了宝贵的见解.
- 在大脑和外围研究中,正在出现一致的脂管学模式.
- 需要进一步的研究,将脂管学与补充方法相结合.
关键词:
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -生物标志物 生物标志物利皮多米克 (Lipidomics) 是一种消化剂.质谱测量质量谱测量精神病学是一个精神病学.精神分裂症是一种精神分裂症.相关概念视频
Biological Causes of Schizophrenia
51
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
51
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
529
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
529
Negative and Cognitive Symptoms of Schizophrenia
46
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
46


